4.7 Review

Smart drug delivery systems for precise cancer therapy

期刊

ACTA PHARMACEUTICA SINICA B
卷 12, 期 11, 页码 4098-4121

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2022.08.013

关键词

Pharmaceutics; Smart drug delivery system; Stimuli-responsive; Receptor-ligand-based delivery; Nano-drug delivery systems; Precise therapy; Toxicity; Cancer

资金

  1. National Natural Science Foundation of China [81973259, 82073789, 81803472]
  2. project for Innovative Research Group at Higher Educational Institutions in Chongqing (China) [CXQT20006]

向作者/读者索取更多资源

Nano-drug delivery systems play an important role in cancer treatment, but the balance between improved anticancer efficacy and reduced toxicity to normal tissues remains a challenge. Smart stimuli-responsive delivery strategies offer opportunities for advanced tumor specificity and controlled release behavior. The development of nanotechnology, material sciences, and biomedical sciences has enabled the creation of diverse and versatile smart drug delivery systems.
Nano-drug delivery strategies have been highlighted in cancer treatment, and much effort has been made in the optimization of bioavailability, biocompatibility, pharmacokinetics profiles, and in vivo distributions of anticancer nano-drug delivery systems. However, problems still exist in the delicate bal-ance between improved anticancer efficacy and reduced toxicity to normal tissues, and opportunities arise along with the development of smart stimuli-responsive delivery strategies. By on-demand responsiveness towards exogenous or endogenous stimulus, these smart delivery systems hold promise for advanced tumor-specificity as well as controllable release behavior in a spatial-temporal manner. Meanwhile, the blossom of nanotechnology, material sciences, and biomedical sciences has shed light on the diverse modern drug delivery systems with smart characteristics, versatile functions, and modification possibil-ities. This review summarizes the current progress in various strategies for smart drug delivery systems against malignancies and introduces the representative endogenous and exogenous stimuli-responsive smart delivery systems. It may provide references for researchers in the fields of drug delivery, biomate-rials, and nanotechnology.(c) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据